UNSW Graduate Certificate in Commercial Biotechnology is an online, two-year part-time coursework program.  

This program has been meticulously designed and is aimed at early to mid-career, science-trained professionals working in the Australasian biotechnology industry. 

Enhance Your Skills & Knowledge 

Biotechnology is a fast-growing industry in Australia and South-East Asia. 

Our online program ensures you learn and develop key capabilities in the management and commercialisation of biotechnology innovations across the financial, regulatory and cultural complexities of global markets.  

Scientists with these skills are the drivers of the biotechnology sector’s competitiveness and growth. The Graduate Certificate in Commercial Biotechnology focusing on the business side of biotechnology makes it a unique offer in Australasia. 

100% Online Program 

UNSW Graduate Certificate in Commercial Biotechnology is a 100% online program with small class sizes, allowing for a high standard of academic rigour and a collaborative learning environment. It is delivered by the School of Biotechnology and Biomolecular Sciences. 

Our content focuses on the key issues that need to be effectively addressed for the successful commercialisation of biotechnology-based products including: 

  • intellectual property management 
  • business models and strategy 
  • financial management 
  • international regulatory environments 
  • strategic communication and negotiation.

It’s taught by UNSW’s outstanding STEM educators and industry experts, ensuring the content is responsive to the current and emerging needs in the national and global job markets. 

Your Career

On successful completion of the graduate certificate, you’ll have the opportunity to work as: 

  • An R&D or new product manager 
  • A business development or commercialisation manager in a technology transfer company 
  • An investment analyst  
  • A venture capitalist 
  • A commercialisation consultant/specialist 
  • An innovation facilitator in government funding agencies like AusIndustry 
  • A government funding policymaker. 

What Our Academics Say

Biotechnology innovation is characterised by extensive capital requirements, multi-disciplines, IP reliance, intense competition, collaborations and partnerships, stringent regulation, long lead times and high risk of failure, but also high return on investment. Effective scientists and managers in the biotechnology sector must know how to collectively navigate these webs of commercialisation pathways whilst negotiating progress with the many and varied stakeholders across global markets. 

- Associate Professor Wallace Bridge, Director Biotechnology Programs

What Industry Says

"Biotech is recession-proof," says Dr Chris Nave, Brandon Capital Partners' managing director. The head of Australia's largest life sciences investment firm has more than just the prospect of a coronavirus vaccine on his mind when considering opportunities in the biotech sector in a post-pandemic world.

Read the full article by Emma Koehn in Sydney Morning Herald. 14 September 2020.

Find Out More

You can also find more information on this degree including entry requirements on the UNSW Degree Finder.